Variational

Variational is a developer of an AI-based platform for small-molecule drug discovery. The companys flagship platform, Enki, represents the first commercially available foundation model designed to generate novel, synthesis-ready drug candidates with optimized properties including potency, selectivity, and ADMET profiles. Variational leverages generative AI to accelerate the drug discovery process, enabling pharmaceutical companies to identify and optimize drug candidates more efficiently than traditional methods. The platform supports lead discovery, molecular optimization, and predictive modeling for drug development. Founded in 2019 and headquartered in Vancouver, Canada, Variational has raised approximately 9 million at the Seed stage with 23 employees and investors including Flying Fish Ventures, Alliance of Angels, Merck Global Health Innovation Fund, and Nimbus Synergies.